Does XARELTO Cause Interstitial lung disease? 40 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Interstitial lung disease have been filed in association with XARELTO. This represents 1.1% of all adverse event reports for XARELTO.
40
Reports of Interstitial lung disease with XARELTO
1.1%
of all XARELTO reports
11
Deaths
21
Hospitalizations
How Dangerous Is Interstitial lung disease From XARELTO?
Of the 40 reports, 11 (27.5%) resulted in death, 21 (52.5%) required hospitalization, and 7 (17.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XARELTO. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does XARELTO Cause?
Pulmonary embolism (276)
Deep vein thrombosis (234)
Drug ineffective (199)
Gastrointestinal haemorrhage (198)
Cerebrovascular accident (180)
Haemoglobin decreased (166)
Fall (124)
Anaemia (123)
Haemorrhage (121)
Cerebral haemorrhage (110)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)